Form 4: Corcept Therapeutics President Sells Shares
Insider Transaction (Form 4)
Roberto Wandenkolk Vieira, President, Oncology of Corcept Therapeutics Inc, sold 8,333 shares of common stock on October 2, 2026.
Summary
- Option exercise/conversion: acquired 8,333 Common Stock at $21.63 ($180,243) on October 2, 2026; holds 12,279 after (Direct).
- Open-market sale: disposed of 1,100 Common Stock at $114.52 ($125,973) on October 2, 2026; holds 11,179 after (Direct).
- Open-market sale: disposed of 2,086 Common Stock at $115.73 ($241,412) on October 2, 2026; holds 9,093 after (Direct).
- Open-market sale: disposed of 5,147 Common Stock at $116.58 ($600,063) on October 2, 2026; holds 3,946 after (Direct).
- Option exercise/conversion: disposed of 8,333 Stock option (right to buy) on October 2, 2026; holds 133,334 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $967,448 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Roberto Wandenkolk Vieira — Officer (President, Oncology)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Option exercise/conversion | Common Stock | 8,333 | $22 | $180.2K | 12,279 |
| 2026-10-02 | Open-market sale | Common Stock | 1,100 | $115 | $126.0K | 11,179 |
| 2026-10-02 | Open-market sale | Common Stock | 2,086 | $116 | $241.4K | 9,093 |
| 2026-10-02 | Open-market sale | Common Stock | 5,147 | $117 | $600.1K | 3,946 |
| 2026-10-02 | Option exercise/conversion | Stock option (right to buy) | 8,333 | — | — | 133,334 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Option exercise/conversion (8,333 shares) |
| 2026-10-02 | Open-market sale (1,100 shares) |
| 2026-10-02 | Open-market sale (2,086 shares) |
| 2026-10-02 | Open-market sale (5,147 shares) |
| 2026-10-02 | Option exercise/conversion (8,333 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Roberto Wandenkolk Vieira
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.